{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:46Z","timestamp":1792786126228,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute of Dermatology","id":[{"id":"https:\/\/ror.org\/02j6cz137","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Medical Services"},{"DOI":"10.13039\/501100004397","name":"Ministry of Public Health, Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ultraviolet (UV) phototherapy is a cost-effective, guideline-recommended treatment for moderate-to-severe psoriasis, supported by extensive evidence demonstrating its long-term safety and clinical efficacy. As a foundational therapeutic option in routine dermatological practice, access to phototherapy contributes meaningfully to sustained disease control and overall patient outcomes. Nevertheless, comprehensive nationwide data describing real-world utilization, particularly within universal health coverage systems, remain limited. A clearer understanding of patterns of access may therefore offer valuable insight into the organization and delivery of dermatological care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To quantify socioeconomic and regional inequality in UV phototherapy utilization and identify determinants of access within a universal health coverage system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nationwide cross-sectional study (January\u2013December 2023) integrated individual-level administrative health insurance data with a facility-based survey conducted across Thailand\u2019s 13 health regions to assess the availability of dermatologists and UV phototherapy devices. Patients with psoriasis (N = 49 219) were identified using International Classification of Diseases (ICD)-10 codes L40.0\u2013L40.9. Moderate-to-severe disease (n = 16 188) was defined using treatment-based proxies, including receipt of phototherapy, systemic agents or biologic therapies identified through ICD-9 procedure codes and Thai Medicine Terminology drug codes. The primary outcome was phototherapy utilization. Multivariable logistic regression was applied to estimate adjusted odds ratios. Socioeconomic inequality was quantified using the Concentration Index and concentration curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 49 219 identified patients with psoriasis (202 776 encounters), 16 188 were classified as having moderate-to-\u00adsevere disease. Of these, only 3.3% received UV phototherapy. Utilization was concentrated in higher-income provinces, as reflected by a positive Concentration Index of 0.213. In multivariable analysis, access to phototherapy was independently associated with age, psoriasis subtype, insurance scheme, geographical region, provincial income level, and the availability of dermatologists and phototherapy devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Access to phototherapy in Thailand remains limited and unequally distributed despite universal insurance coverage. Reducing disparities in workforce distribution and service capacity may enhance equitable access to this core dermatological treatment modality and support more equitable long-term disease control in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzag110","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:00:57Z","timestamp":1784732457000},"page":"785-792","source":"Crossref","is-referenced-by-count":0,"title":["Inequality and determinants of access to phototherapy among patients with psoriasis in Thailand"],"prefix":"10.1093","volume":"6","author":[{"given":"Chutima","family":"Churee","sequence":"first","affiliation":[{"name":"Photodermatology Division, Institute of Dermatology,\u00a0Department of Medical Services, Ministry of Public Health , Bangkok ,","place":["Thailand"]},{"name":"Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Hanvoravongchai","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University , Bangkok ,","place":["Thailand"]},{"name":"Saw Swee Hock School of Public Health, National University of Singapore , Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanapoom","family":"Rattananupong","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026092919521501400_vzag110-B1","article-title":"Global psoriasis burden 1990\u20132021: evolving patterns and sociodemographic correlates in the Global Burden of Disease 2021 update","volume":"13","author":"Li","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"2026092919521501400_vzag110-B2","first-page":"569","article-title":"Global trends and future predictions of psoriasis burden: insights from the GBD 2021 study","volume":"15","author":"Gu","year":"2025","journal-title":"Psoriasis (Auckl)"},{"key":"2026092919521501400_vzag110-B3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/bjd.21669","article-title":"British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022","volume":"187","author":"Goulden","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026092919521501400_vzag110-B4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026092919521501400_vzag110-B5","doi-asserted-by":"crossref","DOI":"10.35702\/Derm.10028","article-title":"Racial disparities in psoriasis treatment: a review of prescription patterns and outcomes across White and skin of color populations","volume":"5","author":"Hash","year":"2025","journal-title":"Dermis"},{"key":"2026092919521501400_vzag110-B6","doi-asserted-by":"crossref","DOI":"10.46981\/sfjhv5n4-001","article-title":"Exploring health disparities: a single-institution analysis of time to diagnosis in adolescent psoriasis patients","volume":"5","author":"Khadka","year":"2024","journal-title":"South Florida J Health"},{"key":"2026092919521501400_vzag110-B7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bjd.21594","article-title":"Delay in diagnosis and treatment of patients with psoriasis: a population-based cross-sectional study","volume":"187","author":"Nielsen","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026092919521501400_vzag110-B8","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s13555-025-01541-9","article-title":"Systematic literature reviews on the disease burden of pediatric psoriasis","volume":"15","author":"Sanchez","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026092919521501400_vzag110-B9","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2365820","article-title":"Health disparities in psoriasis: geographic barriers to access in the United States","volume":"35","author":"Seigel","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"2026092919521501400_vzag110-B10","article-title":"Limited access to dermatology specialty care: barriers and teledermatology","volume":"13","author":"Duniphin","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"2026092919521501400_vzag110-B11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamadermatol.2018.3022","article-title":"Comparison of dermatologist density between urban and rural counties in the United States","volume":"154","author":"Feng","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2026092919521501400_vzag110-B12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jan.14604","article-title":"A mixed methods analysis of access barriers to dermatology care in a rural state","volume":"77","author":"Cyr","year":"2021","journal-title":"J Adv Nurs"},{"key":"2026092919521501400_vzag110-B13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Med Care"},{"key":"2026092919521501400_vzag110-B14","first-page":"54","article-title":"Cost variations in outpatient and inpatient services among three health insurance schemes in Thai public hospitals","volume":"17","author":"Jithitikulchai","year":"2023","journal-title":"J Health Syst Res"},{"key":"2026092919521501400_vzag110-B15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.det.2024.02.009","article-title":"Disparities in care for psoriasis","volume":"42","author":"Drozdowski","year":"2024","journal-title":"Dermatol Clin"},{"key":"2026092919521501400_vzag110-B16","volume-title":"Equity in health service utilisation under Thailand\u2019s universal health coverage: evidence from household surveys.","author":"Jithitikulchai","year":"2020"},{"key":"2026092919521501400_vzag110-B17","first-page":"569","article-title":"Health disparities in dermatologic care","volume":"148","author":"Buster","year":"2012","journal-title":"Arch Dermatol"},{"key":"2026092919521501400_vzag110-B18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026092919521501400_vzag110-B19","first-page":"e256","article-title":"Disparities in psoriasis treatment in South Korea: a population-based study","volume":"55","author":"Kelly","year":"2016","journal-title":"Int J Dermatol"},{"key":"2026092919521501400_vzag110-B20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ijd.17236","article-title":"Disparities and barriers to the access of biologics in moderate-to-severe adult psoriasis","volume":"63","author":"Wan","year":"2024","journal-title":"Int J Dermatol"},{"key":"2026092919521501400_vzag110-B21","first-page":"335","article-title":"Unmet need and inequity in access to health care","volume":"10","author":"Allin","year":"2009","journal-title":"Eur J Health Econ"},{"key":"2026092919521501400_vzag110-B22","volume-title":"Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation","author":"O\u2019Donnell","year":"2008"},{"key":"2026092919521501400_vzag110-B23","author":"U.S. Department of Health and Human Services"},{"key":"2026092919521501400_vzag110-B24","author":"DermNet New Zealand Trust"},{"key":"2026092919521501400_vzag110-B25","author":"Techamontrikul"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/785\/69789921\/vzag110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/785\/69789921\/vzag110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:52:28Z","timestamp":1790725948000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/5\/785\/8739832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzag110","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,22]]}}}